Skip to main navigation Skip to search Skip to main content

Neutralizing Nanobodies targeting diverse chemokines effectively inhibit chemokine function

  • C. Blanchetot
  • , D. Verzijl
  • , A. Mujic-Delic
  • , L. Bosch
  • , L. Rem
  • , R. Leurs
  • , C.T. Verrips
  • , M. Saunders
  • , H. Haard de
  • , M.J. Smit

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Background: Chemokines play a prominent role in inflammatory diseases. Results: Nanobodies targeting chemokines display high affinity and potently neutralize chemokine-induced receptor binding and signaling. Conclusion: Neutralizing Nanobodies targeting chemokines effectively inhibit chemokine function. Significance: Nanobodies directed against inflammatory and homeostatic chemokines form a promising new class of potent and specific inhibitors of chemokine function, to be used for research and therapeutic purposes. © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.
Original languageEnglish
Pages (from-to)25173-25182
JournalJournal of Biological Chemistry
Volume2013
Issue number288
DOIs
Publication statusPublished - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Neutralizing Nanobodies targeting diverse chemokines effectively inhibit chemokine function'. Together they form a unique fingerprint.

Cite this